Laila Tabatabai, MD

Associate Professor of Clinical Medicine Director, Houston Methodist Bone Health Initiative
Houston Methodist Hospital, United States

Laila S. Tabatabai, MD, CCD. Associate Professor of Clinical Medicine, Division of Endocrinology, Diabetes & Metabolism, Houston Methodist Hospital. Director, Houston Methodist Bone Health Initiative. Dr. Tabatabai completed her endocrinology fellowship training at Johns Hopkins Hospital. She joined Houston Methodist in 2014 and created the institution's Bone Health Initiative, a multidisciplinary program targeting post-fracture and osteoporosis patients. Dr. Tabatabai is an expert in rare bone diseases, including X-linked hypophosphatemic rickets and hypophosphatasia. She has extensive involvement in osteoporosis education, both for trainees (she served as Methodist's endocrinology fellowship program director) and at a national level for physicians of all specialties. Dr. Tabatabai currently serves as Vice-Chair for AACE's Bone & Parathyroid DSN.

Disclosure information not submitted.

Presentation(s):

• DSN Year-in-Review: Bone and Parathyroid

  Thursday, May 9, 2024
  11:30 AM – 12:15 PM CDT

• Anabolic Therapy for the Treatment of Osteoporosis In Men and Postmenopausal Women at High Risk for Fracture by Radius (Lunch Product Theater)

  Saturday, May 11, 2024
  12:15 PM – 1:00 PM CDT